meningitis_b_vaccine_flashcards

Question 1

Which meningococcal serotypes have children in the UK been routinely immunised against for many years?

Answer 1

Serotypes A & C.

Question 2

What became the most common cause of bacterial meningitis in the UK after routine immunisation against serotypes A & C?

Answer 2

Meningococcal B.

Question 3

What is the name of the vaccine developed against meningococcal B?

Answer 3

Bexsero.

Question 4

What was the initial decision of the Joint Committee on Vaccination and Immunisation (JCVI) regarding Bexsero?

Answer 4

The JCVI initially rejected the use of Bexsero after a cost-benefit analysis.

Question 5

What is the current status of the meningitis B vaccine in the NHS immunisation schedule?

Answer 5

Meningitis B has now been added to the routine NHS immunisation schedule.

Question 6

At what ages are the three doses of the meningitis B vaccine given?

Answer 6

2 months, 4 months, 12-13 months.

Question 7

For which patients is Bexsero available on the NHS apart from the routine immunisation schedule?

Answer 7

Patients at high risk of meningococcal disease, such as people with asplenia, splenic dysfunction, or complement disorder.